ArticleJournal of oncology2022

Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM.

Ching-Ann Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.